ArticleClinical drug investigation2021

Real-Life Response to Erenumab in a Therapy-Resistant Case Series of Migraine Patients From the Province of Québec, Eastern Canada.

Marzieh Eghtesadi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.